Tag: non-alcoholic steatohepatitis

Wave Life Sciences, GSK partner on oligonucleotide-based gene therapies

Raghuram Kadari- December 15, 2022

Wave Life Sciences and GSK have forged a partnership to discover and develop oligonucleotide therapeutics, focusing on new genetic targets, for respiratory diseases. The discovery ... Read More

TERN-201 NASH clinical trial : Terns reports positive results for phase 1 study

pharmanewsdaily- January 12, 2020

TERN-201 NASH clinical trial : Terns Pharmaceuticals said that an ongoing phase 1 trial of its semicarbazide-sensitive amine oxidase (SSAO) inhibitor TERN-201 in non-alcoholic steatohepatitis ... Read More

Viking Therapeutics initiates VOYAGE study for VK2809 in NASH

pharmanewsdaily- November 20, 2019

Viking Therapeutics has initiated the VOYAGE study, a phase 2b clinical trial of its liver-selective thyroid hormone receptor beta agonist VK2809 in patients with biopsy-confirmed ... Read More